Vardhman Polytex Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: December 9, 2025, 7:35 am

Competitors of Vardhman Polytex Ltd

All Competitor Stocks of Vardhman Polytex Ltd

Quarterly Result

Last Updated: August 20, 2025, 1:35 am

Below is a detailed analysis of the quarterly data for Vardhman Polytex Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 59.54 Cr.. The value appears to be declining and may need further review. It has decreased from 81.20 Cr. (Mar 2025) to 59.54 Cr., marking a decrease of 21.66 Cr..
• For Expenses, as of Jun 2025, the value is 57.88 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 83.17 Cr. (Mar 2025) to 57.88 Cr., marking a decrease of 25.29 Cr..
• For Operating Profit, as of Jun 2025, the value is 1.66 Cr.. The value appears strong and on an upward trend. It has increased from -1.97 Cr. (Mar 2025) to 1.66 Cr., marking an increase of 3.63 Cr..
• For OPM %, as of Jun 2025, the value is 2.79%. The value appears strong and on an upward trend. It has increased from -2.43% (Mar 2025) to 2.79%, marking an increase of 5.22%.
• For Other Income, as of Jun 2025, the value is 3.74 Cr.. The value appears to be declining and may need further review. It has decreased from 8.53 Cr. (Mar 2025) to 3.74 Cr., marking a decrease of 4.79 Cr..
• For Interest, as of Jun 2025, the value is 3.69 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3.45 Cr. (Mar 2025) to 3.69 Cr., marking an increase of 0.24 Cr..
• For Depreciation, as of Jun 2025, the value is 1.52 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 2.13 Cr. (Mar 2025) to 1.52 Cr., marking a decrease of 0.61 Cr..
• For Profit before tax, as of Jun 2025, the value is 0.19 Cr.. The value appears to be declining and may need further review. It has decreased from 0.98 Cr. (Mar 2025) to 0.19 Cr., marking a decrease of 0.79 Cr..
• For Tax %, as of Jun 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00%.
• For Net Profit, as of Jun 2025, the value is 0.19 Cr.. The value appears to be declining and may need further review. It has decreased from 0.99 Cr. (Mar 2025) to 0.19 Cr., marking a decrease of 0.80 Cr..
• For EPS in Rs, as of Jun 2025, the value is 0.00. The value appears to be declining and may need further review. It has decreased from 0.02 (Mar 2025) to 0.00, marking a decrease of 0.02.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: October 15, 2025, 4:11 am

Growth

Last Updated: September 5, 2025, 1:50 pm

Balance Sheet

Last Updated: December 4, 2025, 2:11 am

Below is a detailed analysis of the balance sheet data for Vardhman Polytex Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:

• For Equity Capital, as of Sep 2025, the value is 46.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 46.00 Cr..
• For Reserves, as of Sep 2025, the value is -266.00 Cr.. The value appears to be improving (becoming less negative). It has improved from -273.00 Cr. (Mar 2025) to -266.00 Cr., marking an improvement of 7.00 Cr..
• For Borrowings, as of Sep 2025, the value is 49.00 Cr.. The value appears to be improving (decreasing). However, Reserves are negative, which is a major warning sign. It has decreased from 50.00 Cr. (Mar 2025) to 49.00 Cr., marking a decrease of 1.00 Cr..
• For Other Liabilities, as of Sep 2025, the value is 458.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 454.00 Cr. (Mar 2025) to 458.00 Cr., marking an increase of 4.00 Cr..
• For Total Liabilities, as of Sep 2025, the value is 286.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 276.00 Cr. (Mar 2025) to 286.00 Cr., marking an increase of 10.00 Cr..
• For Fixed Assets, as of Sep 2025, the value is 99.00 Cr.. The value appears to be declining and may need further review. It has decreased from 114.00 Cr. (Mar 2025) to 99.00 Cr., marking a decrease of 15.00 Cr..
• For CWIP, as of Sep 2025, the value is 2.00 Cr.. The value appears to be declining and may need further review. It has decreased from 3.00 Cr. (Mar 2025) to 2.00 Cr., marking a decrease of 1.00 Cr..
• For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
• For Other Assets, as of Sep 2025, the value is 185.00 Cr.. The value appears strong and on an upward trend. It has increased from 160.00 Cr. (Mar 2025) to 185.00 Cr., marking an increase of 25.00 Cr..
• For Total Assets, as of Sep 2025, the value is 286.00 Cr.. The value appears strong and on an upward trend. It has increased from 276.00 Cr. (Mar 2025) to 286.00 Cr., marking an increase of 10.00 Cr..

However, the Borrowings (49.00 Cr.) are higher than the Reserves (-266.00 Cr.), which may signal higher financial risk.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Vardhman Polytex Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 22, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 21) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 22, the value is -6.96. This value is below the healthy minimum of 5. It has increased from -25.43 (Mar 21) to -6.96, marking an increase of 18.47.
• For Diluted EPS (Rs.), as of Mar 22, the value is -6.96. This value is below the healthy minimum of 5. It has increased from -25.43 (Mar 21) to -6.96, marking an increase of 18.47.
• For Cash EPS (Rs.), as of Mar 22, the value is -0.80. This value is below the healthy minimum of 3. It has increased from -18.86 (Mar 21) to -0.80, marking an increase of 18.06.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 22, the value is -163.10. It has decreased from -156.34 (Mar 21) to -163.10, marking a decrease of 6.76.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 22, the value is -163.10. It has decreased from -156.34 (Mar 21) to -163.10, marking a decrease of 6.76.
• For Revenue From Operations / Share (Rs.), as of Mar 22, the value is 416.66. It has increased from 228.13 (Mar 21) to 416.66, marking an increase of 188.53.
• For PBDIT / Share (Rs.), as of Mar 22, the value is 27.98. This value is within the healthy range. It has increased from 7.62 (Mar 21) to 27.98, marking an increase of 20.36.
• For PBIT / Share (Rs.), as of Mar 22, the value is 21.83. This value is within the healthy range. It has increased from 1.04 (Mar 21) to 21.83, marking an increase of 20.79.
• For PBT / Share (Rs.), as of Mar 22, the value is -6.95. This value is below the healthy minimum of 0. It has increased from -25.43 (Mar 21) to -6.95, marking an increase of 18.48.
• For Net Profit / Share (Rs.), as of Mar 22, the value is -6.96. This value is below the healthy minimum of 2. It has increased from -25.43 (Mar 21) to -6.96, marking an increase of 18.47.
• For NP After MI And SOA / Share (Rs.), as of Mar 22, the value is -6.96. This value is below the healthy minimum of 2. It has increased from -25.43 (Mar 21) to -6.96, marking an increase of 18.47.
• For PBDIT Margin (%), as of Mar 22, the value is 6.71. This value is below the healthy minimum of 10. It has increased from 3.33 (Mar 21) to 6.71, marking an increase of 3.38.
• For PBIT Margin (%), as of Mar 22, the value is 5.23. This value is below the healthy minimum of 10. It has increased from 0.45 (Mar 21) to 5.23, marking an increase of 4.78.
• For PBT Margin (%), as of Mar 22, the value is -1.66. This value is below the healthy minimum of 10. It has increased from -11.14 (Mar 21) to -1.66, marking an increase of 9.48.
• For Net Profit Margin (%), as of Mar 22, the value is -1.66. This value is below the healthy minimum of 5. It has increased from -11.14 (Mar 21) to -1.66, marking an increase of 9.48.
• For NP After MI And SOA Margin (%), as of Mar 22, the value is -1.66. This value is below the healthy minimum of 8. It has increased from -11.14 (Mar 21) to -1.66, marking an increase of 9.48.
• For Return on Networth / Equity (%), as of Mar 22, the value is 0.00. This value is below the healthy minimum of 15. There is no change compared to the previous period (Mar 21) which recorded 0.00.
• For Return on Capital Employeed (%), as of Mar 22, the value is -13.49. This value is below the healthy minimum of 10. It has decreased from -0.67 (Mar 21) to -13.49, marking a decrease of 12.82.
• For Return On Assets (%), as of Mar 22, the value is -4.75. This value is below the healthy minimum of 5. It has increased from -18.55 (Mar 21) to -4.75, marking an increase of 13.80.
• For Long Term Debt / Equity (X), as of Mar 22, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 21) which recorded 0.00.
• For Total Debt / Equity (X), as of Mar 22, the value is -1.45. This value is within the healthy range. It has increased from -1.50 (Mar 21) to -1.45, marking an increase of 0.05.
• For Asset Turnover Ratio (%), as of Mar 22, the value is 2.94. It has increased from 1.65 (Mar 21) to 2.94, marking an increase of 1.29.
• For Current Ratio (X), as of Mar 22, the value is 0.13. This value is below the healthy minimum of 1.5. It has increased from 0.08 (Mar 21) to 0.13, marking an increase of 0.05.
• For Quick Ratio (X), as of Mar 22, the value is 0.07. This value is below the healthy minimum of 1. It has increased from 0.05 (Mar 21) to 0.07, marking an increase of 0.02.
• For Inventory Turnover Ratio (X), as of Mar 22, the value is 22.61. This value exceeds the healthy maximum of 8. It has increased from 18.48 (Mar 21) to 22.61, marking an increase of 4.13.
• For Interest Coverage Ratio (X), as of Mar 22, the value is 0.97. This value is below the healthy minimum of 3. It has increased from 0.28 (Mar 21) to 0.97, marking an increase of 0.69.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 22, the value is 0.75. This value is below the healthy minimum of 3. It has increased from 0.03 (Mar 21) to 0.75, marking an increase of 0.72.
• For Enterprise Value (Cr.), as of Mar 22, the value is 583.32. It has increased from 560.43 (Mar 21) to 583.32, marking an increase of 22.89.
• For EV / Net Operating Revenue (X), as of Mar 22, the value is 0.62. This value is below the healthy minimum of 1. It has decreased from 1.10 (Mar 21) to 0.62, marking a decrease of 0.48.
• For EV / EBITDA (X), as of Mar 22, the value is 9.35. This value is within the healthy range. It has decreased from 33.01 (Mar 21) to 9.35, marking a decrease of 23.66.
• For MarketCap / Net Operating Revenue (X), as of Mar 22, the value is 0.05. This value is below the healthy minimum of 1. It has decreased from 0.07 (Mar 21) to 0.05, marking a decrease of 0.02.
• For Price / BV (X), as of Mar 22, the value is -0.14. This value is below the healthy minimum of 1. It has decreased from -0.10 (Mar 21) to -0.14, marking a decrease of 0.04.
• For Price / Net Operating Revenue (X), as of Mar 22, the value is 0.05. This value is below the healthy minimum of 1. It has decreased from 0.07 (Mar 21) to 0.05, marking a decrease of 0.02.
• For EarningsYield, as of Mar 22, the value is -0.28. This value is below the healthy minimum of 5. It has increased from -1.48 (Mar 21) to -0.28, marking an increase of 1.20.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness